SCHEMBL12440663

SCHEMBL12440663

Clc1ccc(-c2ccc3nc(-c4ccc(CN5CCCC5)cc4)ccc3c2)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.53
ALDH1A1 P00352 1/20 0.53
NPC1 O15118 1/20 0.51
RAB9A P51151 1/20 0.51
MCHR1 Q99705 7/20 0.50
CHRM1 P11229 4/20 0.50
HTR2A P28223 4/20 0.50
HRH4 Q9H3N8 1/20 0.50
HRH3 Q9Y5N1 1/20 0.50
LSS P48449 2/20 0.49
HTR2C P28335 2/20 0.48
PARP1 P09874 3/20 0.47
BACE1 P56817 1/20 0.47
CYP2D6 P10635 2/20 0.47
CYP2C19 P33261 1/20 0.47
KCNH2 Q12809 1/20 0.46
DRD2 P14416 2/20 0.45
DRD4 P21917 2/20 0.45
DRD3 P35462 2/20 0.45
PARP2 Q9UGN5 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12440113 0.81 MCHR1 (0.60) MCHR1CHRM1HTR2AHRH3CYP2D6
SCHEMBL2325485 0.81 MCHR1 (0.54) KDM4EALDH1A1NPC1RAB9AMCHR1
SCHEMBL12441354 0.81 NPC1 (0.51) KDM4ENPC1RAB9AMCHR1HTR2C
SCHEMBL10039087 0.80 BACE1 (0.62) KDM4EALDH1A1NPC1RAB9ABACE1
SCHEMBL12440591 0.78 MCHR1 (0.52) KDM4EALDH1A1NPC1RAB9AMCHR1
SCHEMBL12440381 0.77 MCHR1 (0.52) NPC1RAB9AMCHR1HTR2CKCNH2
SCHEMBL12440034 0.77 KDM4E (0.60) KDM4EALDH1A1MCHR1CHRM1HTR2A
SCHEMBL11610713 0.77 ALDH1A1 (0.88) KDM4EALDH1A1MCHR1CHRM1HTR2A
SCHEMBL12441623 0.76 MAP4K4 (0.60) MCHR1CHRM1HTR2AHRH3BACE1
SCHEMBL27110695 0.74 POLB (0.53) KDM4EALDH1A1NPC1RAB9AHRH4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2357173-A1 New alkyne compounds with MCH-antagonistic activity and medicaments containing them Boehringer Ingelheim Pharma GmbH & Co. KG (DE) 2011-08-17 EP disclosed